10:06 AM EST - Valeant Pharmaceuticals International, Inc. : announced that it has received two separate requests for additional information from the Federal Trade Commission in connection with Valeant's pending Dermik and Ortho Dermatologics acquisitions. Valeant Pharmaceuticals International, Inc.
shares T.VRX are trading up $0.23 at $40.08.
